# EDGAR Filing Document

**Accession Number:** 0002132261
**File Stem:** 0002132261-26-000001
**Filing Date:** 2026-5
**Character Count:** 6730
**Document Hash:** af467bd7e26286daf75865f744b5923a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002132261-26-000001.hdr.sgml**: 20260518

**ACCESSION NUMBER**: 0002132261-26-000001

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260518

**FILED AS OF DATE**: 20260518

**DATE AS OF CHANGE**: 20260518

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Wedan Steven Robert
- **CENTRAL INDEX KEY:** 0002132261

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-56826
- **FILM NUMBER:** 26995176

**MAIL ADDRESS:**
- **STREET 1:** C/O IMRICOR MEDICAL SYSTEMS, INC.
- **STREET 2:** 400 GATEWAY BLVD
- **CITY:** BURNSVILLE
- **STATE:** MN
- **ZIP:** 55337-2559
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Imricor Medical Systems, Inc.
- **CENTRAL INDEX KEY:** 0002121708
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 204914480
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 400 GATEWAY BLVD.
- **CITY:** BURNSVILLE
- **STATE:** MN
- **ZIP:** 55337
- **BUSINESS PHONE:** (952) 818-8400

**MAIL ADDRESS:**
- **STREET 1:** 400 GATEWAY BLVD.
- **CITY:** BURNSVILLE
- **STATE:** MN
- **ZIP:** 55337

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Wedan Steven Robert<br><sub>(Last) (First) (Middle)</sub><br>C/O IMRICOR MEDICAL SYSTEMS, INC.<br>400 GATEWAY BLVD<br><sub>(Street)</sub><br>BURNSVILLE, MN 55337-2559<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Imricor Medical Systems, Inc. [ IMR ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-05-18 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_President and CEO_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Class A Common Stock | 5083586<sup>(1)(2)</sup> | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Stock Option (right to buy) | <sup>(3)</sup> | 2029-03-15 | Class A Common Stock | 1060800 | $0.52 | D |  |
| Stock Option (right to buy) | <sup>(4)</sup> | 2029-08-30 | Class A Common Stock | 200000 | $0.98 | D |  |
| Stock Option (right to buy) | <sup>(5)</sup> | 2030-05-13 | Class A Common Stock | 301997 | $0.89 | D |  |
| Stock Option (right to buy) | <sup>(6)</sup> | 2034-05-15 | Class A Common Stock | 445337 | $0.3 | D |  |
| Stock Option (right to buy) | <sup>(7)</sup> | 2035-05-14 | Class A Common Stock | 113973 | $1.07 | D |  |

---

### Footnotes:

(1) The amount of securities beneficially owned in column 2 includes 3,077,573 shares of the issuer's Class A Common Stock underlying the same number of CHESS Depositary Interests ("CDIs"). The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty Limited, a subsidiary of ASX Limited, the company that operates the ASX.

(2) The amount of securities beneficially owned in column 2 includes (i) 1,427,373 shares held jointly with Cherri Wedan, (ii) 20,000 shares held by PENSCO Trust Company LLC Cust FBO Steve Wedan IRA, and (iii) 458,640 shares held by PENSCO Trust Company LLC Cust FBO Steve Wedan Roth IRA.

(3) This option was granted on March 15, 2019, and vested in multiple installments over approximately three years from the grant date. This option is 100% vested.

(4) This option was granted on August 30, 2019, and vested in multiple installments over approximately four years from the grant date. This option is 100% vested.

(5) Represents the vested portion of the option granted on May 13, 2020. This option vested in multiple time-based installments and upon the achievement of certain performance milestones. A portion of this option is not reported here because it remains subject to performance-based vesting conditions that have not yet been achieved.

(6) Represents the vested portion of the option granted on May 15, 2024. This portion vested upon the achievement of a certain performance milestone. A portion of this option is not reported here because it remains subject to performance-based vesting conditions that have not yet been achieved.

(7) Represents the vested portion of the option granted on May 14, 2025. This portion vested upon the achievement of a certain performance milestone. A portion of this option is not reported here because it remains subject to performance-based vesting conditions that have not yet been achieved.

**Signature:** /s/ Steven Robert Wedan  
**Date:** 2026-05-18

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**